FDA’s biosimilar stakeholder submission roundup – Part III
In March 2010, the Biologics Price Competition and Innovation Act of 2009 (BPCIA) became law and established a legal pathway for the... Read More
Pfizer scraps alliance with Biocon for biosimilar insulin and insulin analog products
In October 2010, Pfizer and Biocon announced an alliance to develop biosimilar insulin products. On March 12, 2012, the partnership ended, with... Read More